INSERM U1219, Bordeaux, France.
Univ. de Bordeaux, Bordeaux, France.
Int J Geriatr Psychiatry. 2017 Aug;32(8):849-859. doi: 10.1002/gps.4536. Epub 2016 Jun 30.
The French regulatory agency published in 2006 practice guidelines related to the management of depressive and anxiety disorders. The main objective of the study was to assess their impact regarding use and monitoring of antidepressant drug treatment in older patients. The secondary objective was to identify factors associated with compliance with practice guidelines.
A historical fixed cohort study with dynamic follow-up time was conducted in 16,144 subjects aged 65 years and over, initiating antidepressant treatment and registered in the National Health Insurance Database between 2006 and 2012. Compliance with guidelines was assessed from year to year using segmented regression analysis. Multiple logistic regressions were used to identify factors associated with compliance with guidelines.
Duration of antidepressant treatment was compliant with guidelines in 13.0% of patients aged 65-74 years and 18.5% of patients aged 75 years and over. Biological monitoring was performed in 12.6% of patients aged 65-74 years and 18.5% of patients aged 75 years and over. No significant change of rate of compliance with guidelines was observed over the study period. Compliance of prescriptions with guidelines was associated with patient's age, specialty of the prescriber, presence of chronic disease, year of treatment initiation, and presence of a university hospital in the area of residence.
While treatment duration and biological monitoring were often inadequate in older patients, the publication of guidelines by the French health regulatory authorities did not lead to any significant and sustained improvement in their patterns of antidepressant use. Copyright © 2016 John Wiley & Sons, Ltd.
法国监管机构于 2006 年发布了与抑郁和焦虑障碍管理相关的实践指南。本研究的主要目的是评估其对老年患者抗抑郁药物治疗的使用和监测的影响。次要目标是确定与遵循实践指南相关的因素。
这是一项具有动态随访时间的历史固定队列研究,共纳入了 16144 名年龄在 65 岁及以上、于 2006 年至 2012 年期间开始接受抗抑郁药物治疗并在国家健康保险数据库中注册的患者。使用分段回归分析逐年评估对指南的遵守情况。使用多因素逻辑回归分析确定与遵循指南相关的因素。
在 65-74 岁的患者中,有 13.0%的患者抗抑郁药物治疗持续时间符合指南要求,75 岁及以上的患者中有 18.5%符合要求。在 65-74 岁的患者中,有 12.6%的患者进行了生物学监测,75 岁及以上的患者中有 18.5%进行了生物学监测。在研究期间,没有观察到遵循指南的比率发生显著变化。处方与指南的一致性与患者年龄、处方医生的专业、慢性病的存在、治疗开始的年份以及居住地是否有大学医院有关。
尽管在老年患者中,治疗持续时间和生物学监测往往不足,但法国卫生监管机构发布指南并没有导致抗抑郁药物使用模式的任何显著和持续的改善。